Erratum: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

被引:0
|
作者
M H Bloch
A Landeros-Weisenberger
B Kelmendi
V Coric
M B Bracken
J F Leckman
机构
来源
Molecular Psychiatry | 2006年 / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Correction to: Molecular Psychiatry (2006) 11, 622–632. doi: 10.1038/sj.mp.4001823 Following publication of the above article, the authors noted the following: while the captions for Figures 4 and 5 were correct, the actual figures themselves were incorrectly transposed. They appear correctly below:
引用
收藏
页码:795 / 795
相关论文
共 50 条
  • [1] A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
    M H Bloch
    A Landeros-Weisenberger
    B Kelmendi
    V Coric
    M B Bracken
    J F Leckman
    [J]. Molecular Psychiatry, 2006, 11 : 622 - 632
  • [2] A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
    Bloch, M. H.
    Landeros-Weisenberger, A.
    Kelmendi, B.
    Coric, V.
    Bracken, M. B.
    Leckman, J. F.
    [J]. MOLECULAR PSYCHIATRY, 2006, 11 (07) : 622 - 632
  • [3] Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
    Thamby, Abel
    Jaisoorya, T. S.
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (07) : S51 - S57
  • [4] A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder (vol 11, pg 622, 2006)
    Bloch, M. H.
    Landeros-Weisenberger, A.
    Kelmendi, B.
    Coric, V.
    Bracken, M. B.
    Leckman, J. F.
    [J]. MOLECULAR PSYCHIATRY, 2006, 11 (08) : 795 - 795
  • [5] Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis
    Veale, David
    Miles, Sarah
    Smallcombe, Nicola
    Ghezai, Haben
    Goldacre, Ben
    Hodsoll, John
    [J]. BMC PSYCHIATRY, 2014, 14
  • [6] Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis
    David Veale
    Sarah Miles
    Nicola Smallcombe
    Haben Ghezai
    Ben Goldacre
    John Hodsoll
    [J]. BMC Psychiatry, 14
  • [7] Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder
    Liddell, Malcolm B.
    Aziz, Victor
    Briggs, Patrick
    Kanakkehewa, Nimalee
    Rawi, Omar
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2013, 3 (01) : 15 - 19
  • [8] Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?
    Maina, G
    Albert, U
    Ziero, S
    Bogetto, F
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (01) : 23 - 28
  • [9] Antipsychotic treatment in obsessive-compulsive disorder: a literature review
    Keuneman, RJ
    Pokos, V
    Weerasundera, R
    Castle, DJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (05): : 336 - 343
  • [10] Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder
    Saxena, S
    Wang, D
    Bystritsky, A
    Baxter, LR
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (07) : 303 - 306